Video

Mithu Maheswaranathan, MD: Improving Health Literacy in Patients with SLE

Author(s):

Interventions for patients with systemic lupus erythematosus (SLE) need to address physician/patient communication to improve health outcomes, according to Dr. Maheswaranathan.

According to late-breaking data presented at the American College of Rheumatology (ACR) 2021 Convergence, limited health literacy in patients with systemic lupus erythematosus (SLE) was associated with worsened health outcomes.

Mithu Maheswaranathan, MD, Division of Rheumatology and Immunology, Duke University School of Medicine, and a team of investigators found that limited health literacy in this population led to reduced patient activation, worse patient-centered care, especially regarding physician/patient communication, worse self-efficacy, and higher lupus damage and disease activity compared with patients who have adequate health literacy.

"What was striking," Maheswaranathan said, "was the reported problems on items related to patient/physician communication in the patient-centered care survey."

Many patients reported that they didn't understand the physician's answers to their questions and that their physicians were not spending adequate time with them addressing their concerns.

Maheswaranathan proposed that interventions in the future should have a dual approach by addressing disease management in a health literacy sensitive way, but, also improving the method by which patient care is implemented and provided in the healthcare environment.

"So, interventions that help address these elements of disease self-management from a health literacy perspective can help our patients more effectively manage their disease," Maheswaranathan explained, "and ultimately, we think this is an important next step to improve health outcomes in this vulnerable population."

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
© 2024 MJH Life Sciences

All rights reserved.